Bio-Reference Labs Buys New York-Based Medilabs

Acquisition activity by this publicly traded laboratory helps sustain multi-year growth

CEO SUMMARY: Here is an independent commercial laboratory that shows sustained growth while it maintains profitable operations. One key strategy is the selective acquisition of laboratory business in small, profitable chunks. The sales price paid for Medilabs demonstrates how much decline has occurred to the value of clinical laboratories.

DESPITE THE PROFIT SQUEEZE on commercial laboratories,

Subscriber-Only Content. Please Log In.

You are trying to access subscribers-only content. If you are a subscriber, please log in.

If you are not a subscriber, click here to see subscription offers.

Subscribers will have instant access to the Dark Report library, 1997 - the present, giving you the most convenient, accessible archive available in laboratory business intelligence today!

To read our FREE article previews, go to The Dark Report Insider.

Tags: , , , , , , , , , , , ,

Enter Your Login Credentials

Send this to friend